Answers are grounded in this paper and cite their sources.
Angiogenic‐osteogenic coupling occurs during bone regeneration. Vascularization during bone repair proceeds through three stages: sprouting, plateau, and regression. Insufficient vascularization due to vessel instability and premature regression underlies failed healing of critical‐sized bone defects. Maintaining neovessel stability is therefore crucial for achieving rapid bone regeneration. However, effectively sustaining vascular stability remains a major challenge. Here, we identify the p‐paxillin (p‐PXN)–RAC1 signaling pathway, activated by extracellular matrix (ECM) stiffening, as a key mechanism driving vascular instability and regression. Bone matrix stiffness increases during the early phase of bone repair, accompanied by vigorous angiogenesis. Subsequently, as matrix stiffness continues to rise, vessel regression occurs. ECM stiffening increases angiogenic sprouting while decreasing pericyte recruitment and basement membrane component secretion, disrupting the balance between neovessel formation and vascular maturation, resulting in an unstable, regression‐prone vascular phenotype. Mechanistically, this process is driven by p‐PXN–RAC1‐mediated mechanotransduction. Downregulating p‐PXN at the end of the angiogenic plateau effectively promoted neovessel stabilization and boosted bone regeneration by 1.5‐fold. Our findings underscore the pivotal role of mechanotransduction in vascular stabilization, provide insights into the regulation of vascular homeostasis during bone regeneration, thereby establishing an innovative therapeutic strategy for bone defect repair.
No takes yet. Share an insight, caveat, or question.
Mei et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: